ERBB2 and breast cancer: Among HER2+ and HER2-negative BC, <5% genes were found to be expressed differently within each molecular subtype, and respect to the subtype, the genes significant up-regulated in HER2+ breast cancers, were found enriched for genes located in the 17q12 and 17q21 DNA amplicons.